Clinical trials
Skin Diseases clinical trials
Below are recruiting skin diseases clinical trials, each written for real people, not researchers. We’re tracking 95 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07412691RecruitingPhase 1
Safety study of BG-A3004 in healthy people and skin disease patients
This study tests a new drug (BG-A3004) for safety in healthy volunteers and people with certain skin conditions like alopecia areata, cutaneous lichen planus, or vitiligo. It helps find out if the drug is safe and how the body processes it.
Beijing, Beijing MunicipalityAges 18–60 - NCT07717346RecruitingEarly Phase 1
KB111 topical gel for Hailey-Hailey disease
This trial tests a new topical gel called KB111 for treating Hailey-Hailey disease, a genetic skin condition that causes painful blisters. The study will check if the gel is safe and helps reduce symptoms.
Miami, FloridaAges 12 years+ - NCT06674980Recruiting
Testing placenta-based wound treatment for diabetic and venous leg ulcers
This trial tests if adding a special placenta-based wound covering to standard care helps heal diabetic foot ulcers and venous leg ulcers faster. It's for people with wounds that haven't healed after standard treatment for at least 4 weeks.
Metairie, LouisianaAges 18 years+ - NCT06850311RecruitingPhase 2/Phase 3
Herbal ointment for mild to severe eczema
This trial tests whether a special herbal ointment can help treat atopic dermatitis (eczema). It is for adults with mild, moderate, or severe eczema covering less than 10% of their body surface. The ointment is applied directly to the skin, and participants will also use a gentle, fragrance-free moisturizer.
New Taipei CityAges 18–65 - NCT06917690RecruitingPhase 3
Testing oleogel-S10 for epidermolysis bullosa in Japanese patients
This trial tests a gel called oleogel-S10 on wounds caused by a rare skin condition called epidermolysis bullosa (EB). It is only for people of Japanese descent who have a specific type of EB called junctional or dystrophic EB. The gel is put on the wound to help it heal.
FukuokaAges 3 weeks+ - NCT01631617RecruitingPhase 2
Atopic dermatitis treatments and how they affect skin
This Phase 2 study tests different treatments for atopic dermatitis (eczema) by looking at changes in skin health. It may help people find safer, more effective ways to control moderate to severe eczema and related skin infections.
Bethesda, MarylandAges 2–50 - NCT06924333Enrolling by invitation
Skin bacteria study in eczema
This study looks at the bacteria and other tiny organisms living on your skin to learn more about skin conditions like eczema. It may help doctors understand why some people get these skin problems.
Lund, Skåne CountyAges 18 years+ - NCT06989216Recruiting
Skin imaging study for adults
This trial uses advanced imaging to take detailed pictures of your skin. It may help doctors better understand and diagnose skin conditions.
StockholmAges 18 years+ - NCT07091604Recruiting
Looking at skin color differences in healthy people and patients
This study looks at natural differences in skin color. Researchers measure skin pigmentation in healthy volunteers and people with skin conditions to better understand variation.
Leiden, LeidenAges 18 years+ - NCT06387654Recruiting
Collection of skin samples for immune-related skin diseases
This study collects skin samples and medical information from people with skin conditions caused by their immune system. It helps researchers better understand these diseases and develop new treatments.
ToulouseAges 6–99 - NCT05499091Recruiting
Study rare disease genetics using family and health data
This study tries to find genetic causes for rare diseases that are not yet understood. It uses a national rare-disease data bank and collects consent from patients and sometimes close family members.
AngersAges Any age - NCT02650622Recruiting
Study of genetic and metabolic diseases in children
This study looks at children who may have genetic (inherited) or metabolic (body chemistry) problems, including newborn screening and episodes of trouble. The goal is to better understand these conditions and identify children who may benefit from further care.
Dallas, TexasAges 1 day+ - NCT05723198RecruitingPhase 3
Baricitinib for severe childhood hair loss from alopecia areata
This trial tests whether baricitinib can improve severe alopecia areata (patchy, autoimmune hair loss) in children and teens. It’s meant for people who have had long-lasting, severe hair loss and have tried other treatments without enough benefit.
Birmingham, AlabamaAges 6–17 - NCT06575270Recruiting
Study of skin color and pulse oximeters in children with heart disease
This trial checks how well pulse oximeters (devices that measure oxygen levels) work in children with congenital heart disease who have different skin colors. It aims to make sure these devices are accurate for all children during heart surgery.
New York, New YorkAges Up to 18 years - NCT06976073Recruiting
Skin imaging study using non-invasive scan
This trial uses a special camera to measure the composition and structure of the skin without any needles or cuts. It helps researchers understand how skin varies between people.
StockholmAges 18 years+ - NCT05649098RecruitingEarly Phase 1
Testing dupilumab for itchy inherited genetic skin disorders
This early trial tests whether dupilumab can reduce itching in people with certain inherited (genetic) inflammatory skin conditions. It may help by calming skin inflammation that causes ongoing itch and sleep problems.
Chicago, IllinoisAges 6 months+ - NCT05759780Recruiting
Check how an eye probe measures tissue softness
This study uses a special eye/skin/gum imaging test to measure how tissues behave. It may help researchers improve noninvasive ways to understand eye and tissue health, and in some parts of the study, mild keratoconus.
Boston, MassachusettsAges 18–75 - NCT06614777Recruiting
Darier's disease immune and microbiome study
This study looks at immune markers and gut/skin bacteria in people with Darier's disease. It aims to better understand the condition, which could lead to better treatments in the future.
Toulouse, Centre Hospitalier Universitaire de ToulouseAges 18 years+ - NCT05013944Recruiting
Join a patient registry to support future research
This trial is a “patient registry,” which collects health information over time to help researchers plan and run future studies. It may help by contributing your experience so new treatments can be tested more effectively.
Arlington Heights, IllinoisAges 18 years+ - NCT00344188Recruiting
Study of Leishmania infections
This trial studies people with Leishmania infections (a parasitic disease often from sand fly bites). Researchers aim to better understand and treat the infection, and you may benefit from expert care.
Bethesda, MarylandAges 3–100 - NCT06563323RecruitingPhase 2
Testing Guselkumab for Pyoderma Gangrenosum
This study tests whether guselkumab (Tremfya) can help heal painful ulcers from Pyoderma Gangrenosum (PG). Participants must already be taking steroid medication and have a PG ulcer that is at least 4 cm².
Columbus, OhioAges 18–99 - NCT02504879Recruiting
Study of melorheostosis progression and genetic causes
This study follows adults with suspected or confirmed melorheostosis to understand how the condition develops and what outcomes to expect. It may help researchers better understand the disease and its genetic factors.
Bethesda, MarylandAges 18–90 - NCT00842283Recruiting
Study of how new blood vessels affect skin diseases
This study looks at how new blood vessel growth may be involved in skin conditions. It may help researchers learn whether blocking this process could become a future treatment, and you may contribute by having a skin biopsy.
Irvine, CaliforniaAges 16 years+ - NCT00024479Recruiting
Understanding how rheumatic diseases develop over time
This research study follows people with known or suspected rheumatic diseases (like arthritis, lupus, or similar conditions) to learn how these conditions change and progress naturally. By tracking your health over time, researchers hope to better understand these diseases and improve treatments.
Bethesda, MarylandAges 18–100
Hear when a new Skin Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for skin diseases?
- Yes. Clin2 currently lists 95 recruiting skin diseases studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a skin diseases trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a skin diseases trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.